- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional
- Study aim: To compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving muscle function (metabolism) following moderate exercise in subjects with fatigue-Predominant Post-Acute Sequelae of SARS-CoV-2 as well as the safety and tolerability of AXA1125
- Number of participants enrolled: 41
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- General population
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Dietary
- Lifestyle
External Links
Other information
Funders:
- Axcella Health, Inc
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to